Literature DB >> 12538026

Structure-activity relationships of 6-fluoroquinazolines: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.

Masanori Tobe1, Yoshiaki Isobe, Hideyuki Tomizawa, Takahiro Nagasaki, Fumihiro Obara, Hideya Hayashi.   

Abstract

We synthesized various 6-fluoro-7-(1-piperazino)quinazolines based on the structure of 1 and evaluated their inhibitory activities toward both TNF-alpha production and T cell proliferation responses. Among these compounds, 7a, having the 3,4-(methylenedioxy)phenyl moiety at the C(4)-position of the quinazoline ring, showed both inhibitory activities. Furthermore, the oral treatment with 7a exhibited an anti-inflammatory effect in rats with adjuvant arthritis as well as an inhibitory activity toward LPS-induced TNF-alpha production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538026     DOI: 10.1016/s0968-0896(02)00338-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Synthesis and antifungal bioactivities of 3-alkylquinazolin- 4-one derivatives.

Authors:  Guiping Ouyang; Peiquan Zhang; Gangfang Xu; Baoan Song; Song Yang; Linhong Jin; Wei Xue; Deyu Hu; Ping Lu; Zhuo Chen
Journal:  Molecules       Date:  2006-06-12       Impact factor: 4.411

2.  Microwave assisted synthesis of N-arylheterocyclic substituted-4-aminoquinazoline derivatives.

Authors:  Gang Liu; Song Yang; Baoan Song; Wei Xue; Deyu Hu; Linhong Jin; Ping Lu
Journal:  Molecules       Date:  2006-04-10       Impact factor: 4.411

3.  4-{4-[(4-Oxoquinazolin-3-yl)meth-yl]-1H-1,2,3-triazol-1-yl}butyl acetate.

Authors:  Abdelaaziz Ouahrouch; Moha Taourirte; Hassan B Lazrek; Mohamed El Azhari; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-05

4.  Identification of potential TNF-α inhibitors: from in silico to in vitro studies.

Authors:  Komal Zia; Sajda Ashraf; Almas Jabeen; Maria Saeed; Mohammad Nur-E-Alam; Sarfaraz Ahmed; Adnan J Al-Rehaily; Zaheer Ul-Haq
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.